Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells

BACKGROUND: Currently, the prognosis of patients with non-small cell lung cancer (NSCLC) remains dismal; hence, it is critical to identify effective anti-NSCLC agents with limited side effects. This study aimed to evaluate the therapeutic potential of flavonoid compound vitexin in human NSCLC cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoli, Jiang, Qingfeng, Liu, Huaimin, Luo, Suxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387544/
https://www.ncbi.nlm.nih.gov/pubmed/30797236
http://dx.doi.org/10.1186/s40659-019-0214-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387544/
https://www.ncbi.nlm.nih.gov/pubmed/30797236
http://dx.doi.org/10.1186/s40659-019-0214-y

Ejemplares similares